RUNX1 and colorectal cancer: Despite inherent limitations, the study validated the integral role of the RUNX1-MUC13 axis in the progression of colorectal cancer and promoted further investigations into targeted therapeutic strategies that have the potential to innovate colorectal cancer treatment.